Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Imagineering Finishing to be featured on 21st Century Business Television March 3, 2012

(EMAILWIRE.COM, March 01, 2012 ) Boca Raton, FL --- Metals are an essential component in the function of today’s society. Metals constitute important parts of cars, bikes, planes, surgical tools, computers, and can even be part of your medically repaired body in the form of a knee or hip. Imagineering Finishing Technologies is a provider of metallurgical consulting and process applications in a wide range of markets where high precision and critical tolerances must be met.

Through their dedication to the values of Total Quality Management, Imagineering is a customer centric organization that strives to develop an intimate relationship with each and every one of their customers and employees. This exceptional dynamic ensures their customers receive the best metal finishing solutions possible while ensuring smooth supply chain management
Globally acknowledged as the KnowledgeSource ™ for Metal Finishing, Imagineering provides world class quality and environmental standards. Electroless nickel plating, phosphate and chromate conversion coatings, dry-film lubricants, specialty paints and testing – Imagineering provides metal finishing solutions beyond the surface.

President and CEO F. James Hammer stated, “It is not as important of what we think of ourselves – it’s what the customer experiences that matters the most”

JL Haber, Vice President of Programming at Multi Media Productions, added, “Imagineering Finishing is an innovator and a leader in its industry, which makes the company a natural fit for our show. We are excited to have them on the program.”

About Imagineering Enterprises
Imagineering Enterprises was founded in 1959 by David E. Huber, a Notre Dame School of Metallurgical Science graduate. While working at a National Space science lab, he formed the notion of a company to have as its business mission to innovate to decipher everyday engineering problems related to wear and corrosion of metallic substrates. He developed boutique coatings for aerospace and automotive application during his career and consulted many of the Fortune 1000 industrial firms. He sold his business to the current President/CEO, Jim Hammer, in 1996. Mr. Hammer has used his experience and business education to develop Imagineering into one of the leading applied metal finishing and consulting firms in the world.

To learn more about Imagineering Enterprises, please visit

About 21st Century Business
21st Century Business is an award winning television series produced by Multi-Media Productions. The show features companies providing business viewers an in depth opportunity to find solutions within many industries globally.

21st Century Business airs on CNBC and the Fox Business Network to over 100 million viewers nationwide as well as internationally via DirecTV and Dish Network. The show can also be viewed through video on demand via The series is also available at more than 27 prestigious college universities, including Carnegie Mellon University, Howard University, Dartmouth College and Georgetown University.

For specific market-by-market air dates and times, please e-mail For more information, please visit

Multi-Media Productions USA
Susan Waters
919 732 3070


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Just 5% of Terminally Ill Cancer Patients Fully Understand Prognosis, Study F...
24 May 2016 at 8:19am
Small study looked at cancer patients' understanding of their disease.

Exclusive: Monsanto to reject Bayer bid, seek higher price - sources
24 May 2016 at 7:46am

While Monsanto sees industrial logic in a combination with Bayer and believes a deal would be approved by antitrust and other regulators, the company also has confidence in its standalone plan and believes shareholders deserve a better offer, the people said. The German drugs and crop chemicals group said on Monday it offered Monsanto $122 per share. It was not clear what price Monsanto would be willing to sell for.

1 of 3 deaths in EU avoidable if optimal care was available
24 May 2016 at 7:45am
BRUSSELS (AP) ? The European Union's statistical agency says that one out of three deaths in the 28-nation bloc would be avoidable if optimal health care was available.

Anthem CEO expects U.S. regulatory decision in July
24 May 2016 at 7:22am

Anthem Inc Chief Executive Officer Joseph Swedish said on Tuesday the health insurer was pushing for approval from antitrust regulators reviewing its acquisition of Cigna Corp and expects to hear a decision in July. Swedish said antitrust regulators have asked many questions about its and Cigna's national businesses of managing healthcare benefits paid by large employers, adding that the overall review was moving forward as expected. Swedish, speaking at the UBS Global Healthcare Conference, said Anthem has argued to regulators that the deal will save consumers money as the combined company would be able to cut costs for medical services, he said.

Specialists call for gastric surgery to be standard diabetes treatment
24 May 2016 at 7:02am

By Kate Kelland LONDON (Reuters) - Gastric surgery should be offered as a standard treatment option for people with diabetes and could help them control their condition for years without medication, the world's leading diabetes organizations said on Tuesday. In a joint statement which they said constituted one of the biggest shifts in diabetes treatment guidelines since the advent of insulin, the 45-strong group said bariatric, or metabolic, surgery could have a significant benefit for thousands of patients. Francesco Rubin, a professor and chair of metabolic and bariatric surgery at King's College London and one of the authors of the new guidelines, said many countries across the world are in the midst of "an epidemic of diabetes".

GSK lung drug succeeds in big UK study, after earlier miss
24 May 2016 at 5:48am

By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline's new inhaled medicine Breo proved significantly better than standard care in a large British study that tested it in everyday use, providing a fillip for the product after the failure of another big trial in 2015. GSK said on Tuesday the study, which tested Breo in day-to-day practice across the town of Salford, showed it was superior in reducing attacks of serious breathing difficulties in patients with chronic obstructive pulmonary disease (COPD). GSK said beating optimal standard care was a tough challenge though Deutsche Bank analyst Richard Parkes said the benefit was "modest and of uncertain value given complexities in the trial design".

Linking us together through our resting brains
24 May 2016 at 5:45am

We've all heard weird factoids about brains. For example, dolphins sleep one hemisphere at a time. But, did you know that your brain has a resting state? This is somewhat of a contradictory label since it's hard to define rest when it comes to the human brain. This was noted all the way back in ~60 AD when the Roman stoic philosopher, Seneca,...

Drop in migrant deaths in Mediterranean is hopeful sign, NGO says
24 May 2016 at 5:09am
By Stephanie Nebehay GENEVA (Reuters) - Fewer migrants are dying as they try to cross the Mediterranean to Europe, which may reflect better management of refugee flows and swifter rescue operations, the International Organization for Migration (IOM) said on Tuesday. The death toll included 13 in May, none of them on the eastern Mediterranean route between Turkey and Greece, where arrivals have slowed to a trickle since the European Union struck an agreement with Turkey to get it to curb the flow.

Up against strict laws, Texas women learn do-it-yourself abortions
24 May 2016 at 4:10am
Susanna was young, single, broke and pregnant in southern Texas where, thanks to the state's strict laws, her chances of getting a surgical abortion at a clinic were slim to none. With the help of a friend, some online instructions and quick dash across the Mexican border for some pills, she addressed the issue of unwanted pregnancy in a state where women are finding abortion services too expensive and too far away. Restrictive laws took hold in Texas in 2013, forcing so many clinic closings that fewer than 20 remain to serve 5.4 million women of reproductive age.

Abortion, taboo in Jamaica, makes its way into island dancehalls
24 May 2016 at 4:01am
By Rebekah Kebede KINGSTON, Jamaica (Thomson Reuters Foundation) - Abortion might seem an unlikely topic at a party but in Jamaica, it can be the subject of lyrics that get people dancing and singing along. "If yuh never dash up yuh belly, hold up your hands," a disc jockey might shout out in Patois, meaning "If you've never had an abortion, raise your hands." Abortions are known in Patois with the euphemism "dash weh belly" or dashing away one's belly. Women who have had them are shamed and shunned in much of the island nation's dancehall music.

UCB faces U.S. patent challenge for epilepsy drug
24 May 2016 at 3:37am

The U.S. Patent and Trademark Office (PTO) is to review UCB's patent for its epilepsy drug Vimpat, the latest round in a legal battle between the Belgian pharmaceutical company and generic rivals. U.S. pharmaceuticals group Argentum Pharmaceuticals, which challenged UCB's patent, said in a statement late on Monday that the PTO had granted approval for a review of the sole remaining U.S. patent of UCB's Vimpat drug, due to expire in March 2022. The PTO had concluded that Argentum had established a "reasonable likelihood that it would prevail" in showing that certain claims made by UCB in the patent are "unpatentable", Argentum said, adding a decision was likely within a year.

Greek port workers plan 48-hour walkout against privatizations
24 May 2016 at 2:49am
Greek port workers will walk off the job on Thursday for 48 hours to protest against the sale of the country's two biggest ports, which Athens has promised to international lenders in exchange for much-needed bailout loans. Port workers, who fear job cuts, have staged repeated strikes. "Selling the ports is a mistake, it won't help bring growth," George Gogos, general secretary of the Piraeus Port dock workers' union, told Reuters.

Teenage pregnancies hit record low in England
24 May 2016 at 1:27am

The Lancet has published research showing that rates of teenage pregnancy in England have halved since the start of the Government's Teenage Pregnancy Strategy (TPS). The nationwide strategy was launched back in 1999 by the Labour government and aimed to reduce under-18 conception rates by 50% by 2010.

Loss of Y chromosome linked to Alzheimer's disease: study
24 May 2016 at 1:18am

About one in five men over age 80 lose the Y chromosome from their blood cells, and this condition has now been linked to an increased risk of Alzheimer's disease, researchers said Monday. The condition known a loss of Y, or LOY, is the most common genetic mutation acquired during a man's lifetime. Previous research has shown LOY can raise the likelihood of cancer and is more frequently found in smokers.

South Africa's Ascendis Health buys two European firms, shares rise
24 May 2016 at 1:09am

South Africa's Ascendis Health Ltd said on Tuesday it bought two European companies as part of its plan to expand globally and diversify its pharmaceutical products, sending its shares higher. The health and care company will buy Cyprus-based pharmaceutical firm Remedica Holdings Ltd for between 260 million euros ($291 million) and 335 million euros and sports nutrition company Scitec International for 170 million euros. The firm - which bought Spanish pharmaceutical company Farmalier S.A. in August last year - said it received the backing of 63 percent of its shareholders for the acquisitions which will be funded through a combination of debt, shares and proceeds from a rights issue. is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC